Arbutus Biopharma Corp Logo

Arbutus Biopharma Corp (ABUS): Gewinn- und Verlustrechnung

Takani Score ?
28.7

Preis (11.09.2026)52W Hoch52W Tief
5,12 US Dollar5,45 US Dollar3,5 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
5,503 US Dollar21100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
198.105.74314,195,03

ℹ️
Interaktive Darstellung: Klicke auf beliebige Zeilen, um eine grafische Entwicklung über die Zeit anzuzeigen.
Kennzahl in 1000 USD
TTM 2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Umsatz
181.72014.0836.17118.14139.01910.9886.9146.0115.90010.7001.50024.87315.00015.464,1514.180,79216.304,54721.351,32213.779,4059.639,7515.923,34913.604,33113.291,04112.169,6192.732,0985.072,1313.459,4461.767,91.140,3951.227,371
Herstellungskosten
333631.38073.7001.4271.75347.48157.60157.90062.70061.30051.50538.70021.458,25818.125,42619.489,68522.130,44216.965,31213.248,31712.790,2086.186,09712.509,43430.052,36930.484,96527.161,56919.136,30710.339,835--
Bruttoergebnis
181.68713.7206.17118.14139.01910.988-40.567-51.590-52.000-52.000-59.800-26.632-23.700-5.994,108-3.944,634-3.185,138-779,12-3.185,907-3.608,56715.923,3497.418,23413.291,04112.169,6192.732,0985.072,1313.459,4461.767,91.140,3951.227,371
Brutto-Marge
99,98%97,42%100%100%100%100%-586,74%-858,26%-881,36%-485,98%-3.986,67%-107,07%-158%-38,76%-27,82%-19,54%-3,65%-23,12%-37,43%100%54,53%100%100%100%100%100%100%100%100%
Betriebliche Aufwendungen
34.47140.77182.49096.244104.47584.51017.23992.31137.80058.900431.80075.6909.3006.159,119.047,3447.138,09911.734,195.880,0017.340,46113.284,2599.099,45319.248,93839.804,46437.377,90132.789,05319.870,96610.970,8269.313,4299.981,236
Operativer Gewinn/Verlust
147.216-27.051-76.319-78.103-65.456-73.522-57.806-143.901-89.800-110.900-491.600-102.322-33.000-12.153,218-12.991,978-10.323,237-12.513,31-9.065,908-10.949,0282.639,09-1.681,219-5.957,897-27.634,845-34.645,803-27.716,922-16.411,52-9.202,926-8.173,034-8.753,865
Operative Marge
81,01%-192,08%-1.236,74%-430,53%-167,75%-669,11%-836,07%-2.393,96%-1.522,03%-1.036,45%-32.773,33%-411,38%-220%-78,59%-91,62%-63,32%-58,61%-65,79%-113,58%16,57%-12,36%-44,83%-227,08%-1.268,1%-546,46%-474,4%-520,56%-716,68%-713,22%
Zinsen (Netto)
3.4103.9716.4484.707466-2.730-3.27032.8471.277-25.112-853-539,996-47-76,907-106,94-156,333--1.022,703-1.606,665--------
Zinsausgaben
76971374591.7262.8574.0112.1082002611.391674853539,9964776,907106,94156,333-1.022,7031.606,665--------
Zinseinnahmen
3.4864.0686.5855.1662.1921277412.1113.0471.5381.39125.786-----------------
Andere Ausgaben
-2.42810.42149-54722-52.66922.481-25.553-923-2.500964.8471.371,012-42.986,856-545,317-99,816259,76769,0694.198,958-21.366,1051.713,1372.167,555-34.645,803-27.716,922-455,258-9.202,926-8.173,034-8.753,865
Gewinn vor Steuern
153.054-33.501-69.920-72.849-65.012-76.247-63.745-166.379-61.400-108.700-489.100-77.306-38.700-14.064,22629.947,878-9.854,827-12.520,434-9.482,001-11.718,097-2.582,57118.078,221-7.671,034-29.802,4---15.956,262---
Steueraufwand
----0,0014.4441.1041.466-12.656-4.300-24.300-105.000-16.1851001.911,0083.722,344-590,694-99,816259,763.375,925--2,306388,3248.946,007-483,803-852,143-2.326,629-00
Minderheitenanteil
---0,001--1.104-1.466-------1.911,008-3.801,678-9.264,132-12.420,618-9.741,761-15.094,022-2.582,5710-8.059,358-38.748,407483,803852,143-13.629,633-8.173,0338.753,865
Nettogewinn/-verlust
153.054-33.501-69.920-72.849-69.456-76.247-63.745-153.723-57.100-84.400-384.100-61.121-38.800-14.064,22630.027,212-----18.080,527-------8.173,034-8.753,865
Netto-Marge
84,23%-237,88%-1.133,04%-401,57%-178,01%-693,91%-921,97%-2.557,36%-967,8%-788,79%-25.606,67%-245,73%-258,67%-90,95%211,75%-%-%-%-%-%132,9%-%-%-%-%-%-%-716,68%-713,22%

Kennzahlen dieser Seite im Lexikon

Weitere Informationen findest du im Takani-Lexikon.

Zum vollständigen Lexikon